Please use this identifier to cite or link to this item:
Title: Heparin : its use in thrombo-embolic disease
Authors: Gatt, Anthony
Keywords: Heparin -- Side effects
Heparin -- Therapeutic use
Heparin -- Toxicology
Issue Date: 1983-01
Publisher: Chamber of Pharmacists - Trade Union
Citation: Gatt, A. (1983). Heparin : its use in thrombo-embolic disease. The Pharmacist, 5, 9-29.
Abstract: The essential factors of risk leading to thrombo-embolic conditions are: age above forty, obesity, cancer, phlebitis and the contraceptive pill. The last ten years have seen an up-surge of interest in the use of heparin to prevent venous-thrombo-embolic disease. Clinical trials have established that low dose heparin provides effective prophylaxis not only against deep vein thrombosis but also against deaths from post-operative pulmonary embolism.
Appears in Collections:The Pharmacist, Issue 5
The Pharmacist, Issue 5

Files in This Item:
File Description SizeFormat 
ThePharmacist5A1.pdf111.09 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.